Genetic Technologies Ltd (GTG.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2019 | 12-2018 | 06-2018 | 12-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,132 | 3,235 | 5,487 | 7,594 | 10,988 |
| Marketable Securities | 53 | N/A | 4 | N/A | 3 |
| Receivables | 819 | 481 | 301 | 353 | 426 |
| Inventories | 32 | N/A | 59 | N/A | 77 |
| TOTAL | $3,196 | $4,014 | $5,991 | $8,223 | $11,632 |
| Non-Current Assets | |||||
| PPE Net | 69 | 102 | 175 | 323 | 477 |
| TOTAL | $69 | $102 | $175 | $323 | $477 |
| Total Assets | $3,265 | $4,116 | $6,166 | $8,547 | $12,108 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 590 | 602 | 536 | 633 | 398 |
| Accrued Expenses | 347 | N/A | 187 | N/A | 304 |
| TOTAL | $1,493 | $1,005 | $1,451 | $1,183 | $1,465 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1 | 92 | 3 | 31 | 64 |
| TOTAL | $1 | $92 | $3 | $31 | $64 |
| Total Liabilities | $1,494 | $1,097 | $1,454 | $1,213 | $1,529 |
| Shareholders' Equity | |||||
| Common Shares | 125,499 | 123,719 | 122,373 | 122,373 | 122,383 |
| Retained earnings | -129,738 | -126,435 | -123,312 | -121,148 | -117,848 |
| Other shareholders' equity | 6,010 | 5,735 | 5,651 | 6,108 | 6,044 |
| TOTAL | $1,771 | $3,019 | $4,712 | $7,333 | $10,579 |
| Total Liabilities And Equity | $3,265 | $4,116 | $6,166 | $8,547 | $12,108 |